Skip to content

Adjuvant ketogenic diet and metastatic colorectal cancer

Assessment of the adjuvant ketogenic diet effect on therapeutic outcomes in metastatic colorectal cancer patients

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210919052515N2
Enrollment
42
Registered
2021-11-09
Start date
2021-10-23
Completion date
Unknown
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon cancer. Malignant neoplasm of colon

Interventions

Intervention 1: Intervention group: Patients will be received the ketogenic diet for three months in addition to the standard chemotherapy protocol. The ketogenic diet is a low-carb, high-fat diet. Th

Sponsors

Oroumia University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with stage 4 of colorectal cancer Age over 18 years

Exclusion criteria

Exclusion criteria: Lipid metabolism disorders such as carnitine deficiency Patients with liver failure Metastasis to more than 50% in liver tissue History of gastric and pancreatic surgeries Renal cell carcinoma Type 1 diabetes

Design outcomes

Primary

MeasureTime frame
Response to treatment including primary tumor and metastasis size before and after the intervention. Timepoint: Before and three months after the intervention. Method of measurement: With CT scan imaging in millimeters.

Secondary

MeasureTime frame
Ketone body. Timepoint: Before and three months after the intervention. Method of measurement: Ketone meter in blood serum (mM/L).;Carcinoembryonic antigen (CEA). Timepoint: Before and three months after the intervention. Method of measurement: ELISA test (ng/mL).;Vascular endothelium growth factor expression (VEGF). Timepoint: Before and three months after the intervention. Method of measurement: Blood serum (Pg/mL).;C-Reactive Protein (CRP). Timepoint: Before and three months after the intervention. Method of measurement: Blood serum (mg/L).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Naser Masoudi

Oroumia University of Medical Sciences

dr.nasmasoudi@gmail.com+98 44 3337 9924

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026